Sam Kintz

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ELVN

Current role

CEO, Board Member

2025-12-11–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Enliven Therapeutics, Inc. (ELVN)	M.B.A. Former President and Chief Executive Officer	$624,154	—	—	$7,952,553	$316,800	$15,140	$8,908,647
2024	Enliven Therapeutics, Inc. (ELVN)	M.B.A. President and Chief Executive Officer	$600,000	—	—	$4,487,860	$360,000	$13,800	$5,461,660
2023	Enliven Therapeutics, Inc. (ELVN)	M.B.A. President and Chief Executive Officer	$561,190	—	—	$7,413,342	$302,500	$2,000	$8,279,032
2022	Enliven Therapeutics, Inc. (ELVN)	M.B.A. President and Chief Executive Officer	$400,000	—	—	$126,839	$195,000	$2,000	$723,839

Earnings-call appearances and filed executive appointments or departures, newest first.